The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

7 articles for M Liao


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Small-Molecule Drug Discovery in Triple Negative Breast Cancer: Current Situation and Future Directions.EBI
Sichuan University
Structure-based discovery of potent inhibitors of Axl: design, synthesis, and biological evaluation.EBI
Hunan Normal University
An overview of Sirtuins as potential therapeutic target: Structure, function and modulators.EBI
Sichuan University
Synthesis of a new inhibitor of breast cancer resistance protein with significantly improved pharmacokinetic profiles.EBI
Takeda Pharmaceuticals International
Structural Modification of Natural Product Ganomycin I Leading to Discovery of a α-Glucosidase and HMG-CoA Reductase Dual Inhibitor Improving Obesity and Metabolic Dysfunction in Vivo.EBI
University of Chinese Academy of Sciences
Biaryl kinase inhibitorsBDB
Bristol-Myers Squibb
Synthesis and in vitro Evaluation of Novel Indole-Based Sigma Receptors Ligands.BDB
Yeditepe University